Ultrastructural morphometric image analysis applied to estimation of condensed chromatin in normal and neoplastic lymphocytes

Abstract

Currently, quantitative studies of malignant lymphoma are being performed in an attempt to improve the classification of non-Hodgkin's lymphoma (NHL) for diagnostic, prognostic, and therapeutic purposes. Morphometric image analysis is one method that can be employed in cases of NIIL to obtain objective data of nuclear parameters; condensed chromatin being a compartment of the nucleus best measured at the ultrastructural level. This report assesses similarities or differences in the amount, distribution, and arrangement of condensed chromatin in nuclear profiles of normal and neoplastic lymphocytes in human surgical biopsy specimens. Morphometric data derived from electron micrographs of lymphocytes in germinal centers of lymph nodes with reactive hyperplasia (three cases) and small cell types of NHL (two examples of malignant lymphoma, well differentiated lymphocytic type (ML,WDL) and three cases of malignant lymphoma, poorly differentiated lymphocytic type (ML, PDL)) are compared. Results indicate that the distribution of condensed chromatin, i.e., the size of aggregates, and their spatial placement within the nucleus varies more than the amount 030th n e a n area per profile or mean volume) of this nuclear parameter, and that this applies to normal as well as neoplastic lymphocytes. When a series of condensed chromatin parameters were statistically compared, no major differences could be detected between lymphocytes in normal tissues and those in ML,WDL and ML,PDL, but considerable differences were found in each of the nuclear morphotypes in the individual cases within the groups. This degree of variation in nuclear characteristics within normal tissues and the two lymphoma categories has not been previously recognized. Clearly, the technique of morphometric analysis, as applied to electron micrographs, can provide new and useful data that must be appreciated if classification schemes currently used in NHL are to improve _ * and reflect biologic considerations.